XML 36 R26.htm IDEA: XBRL DOCUMENT
v3.26.1

Accrued Expenses and Other Current Liabilities (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2026
Payables and Accruals [Abstract] |
Summary of Accrued Expenses and Other Current Liabilities | Accrued expenses and other current liabilities consist of the following (in thousands):
|  | June 30, 2026 |  |  | December 31, 2025 |
Accrued clinical trials |  | $ | 5 |  |  | $ | 46 |
Accrued research and development |  |  | — |  |  |  | 12 |
Accrued compensation |  |  | 712 |  |  |  | 1,305 |
Accrued legal |  |  | 23 |  |  |  | 207 |
Accrued other |  |  | 21 |  |  |  | 63 |
Accrued expenses and other current liabilities |  | $ | 761 |  |  | $ | 1,633 |

X
- Definition Accrued expenses and current liabilities + References No definition available. + Details
Name: | inab_AccruedExpensesAndCurrentLiabilitiesTableTextBlock
Namespace Prefix: | inab_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration